Abstract
Glial cell line-derived neurotrophic factor (GDNF) was isolated and cloned by Lin and colleagues (Lin et al., 1993, 1994) as part of a concerted effort to identify new trophic factors for midbrain dopamine (DA) neurons. Since the initial description of GDNF in 1993, studies from a number of laboratories have confirmed its potent effects on DA neurons. In addition, GDNF has been found to play an intricate role in the survival and development of a diverse set of neuronal and nonneuronal cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arenas, E., Trupp, M., Akerud, P., and Ibanez, C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465–1473.
Arnsten, A. F. T., Cai, J. X., Steere, J. C., and Goldman-Rakic, P. S. (1995) Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J. Neurosci. 15, 3429–3439.
Bankiewicz, K. S., Oldfield, E. H., Chiueh, C. C., Doppman, J. L., Jacobowitz, D. M., and Kopin, J. (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci. 39, 7–16.
Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A., and Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomyinduced degeneration in the adult brain. Nature 373, 339–341.
Beck, K. D., Irwin, I., Valverde, J., Brennan, T. J., Langston, J. W., and Hefti, F. (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16, 665–673.
Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgrim, D. M., and Evans, D. A. (1996) Prevalence of parkinsonian signs and associated mortality in a community population of older people. N. Engl. J. Med. 334, 71–76.
Bermingham, N., Hillermann, R., Gilmour, F., Martin, J. E., and Fisher, E. M. C. (1995) Human glial cell line-derived neurotrophic factor (GDNF) maps to chromosome 5. Hum. Genet. 96, 671–673.
Blum, M., and Weickert, C. S. (1995) GDNF mRNA expression in normal postnatal development, aging, and in Weaver mutant mice. Neurobiol. Aging 16, 925–929.
Bowenkamp, K. E., Hoffman, A. F., Gerhardt, G. A., Henry, M. A., Biddle, P., Hoffer, B. J., and Granholm, A.-C. E. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355, 479–489.
Bowenkamp, K. E., Lapchak, P A, Hoffer, B. J., and Bickford, P. C. (1996) Glial cell line-derived neurotrophic factor reverses motor impairment in 16–17 month old rats. Neurosci. Lett. 211, 81–84.
Brozoski, T. J., Brown, R. M., Rosvold, H. E., and Goldman, P. S. (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205, 929–932.
Buj-Bello, A., Buchman, V. L., Horton, A., Rosenthal, A., and Davies, A. M. (1995) GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15, 821–828.
Cass, W. A. (1996) GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. J. Neurosci. 16, 8132–8139.
Cheng, H., Hoffer, B., Strömberg, I., Russell, D., and Olson, L. (1995) The effects of glial cell line-derived neurotrophic factor in fibrin glue on developing dopamine neurons. Exp. Brain Res. 104, 199–206.
Choi-Lundberg, D. L., and Bohn, M. C. (1995) Ontogeny and distribution of glial cell linederived neurotrophic factor (GDNF) mRNA in rat. Develop. Brain Res. 85, 80–88.
Clarkson, E. D., Zawada, W. M., and Freed, C. R. (1995) GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport 7, 145–149.
Cristina, N., Chatellard-Causse, C., Manier, M., and Feuerstein, C. (1995) GDNF: existence of a second transcript in the brain. Mol. Brain Res. 32, 354–357.
Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiowaara, K., Suvanto, P., et al. (1996) GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789–793.
Ebendal, T., Tomac, A., Hoffer, B. J., and Olson, L. (1995) Glial cell line-derived neurotrophic factor stimulates fiber formation and survival in cultured neurons from peripheral ganglia. J. Neurosci. Res. 40, 276–284.
Gash, D. M., Zhang, Z., Cass, W. A., Ovadia, A., Simmerman, L., Martin, D., et al. (1995) Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J. Comp. Neurol. 363, 345–358.
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., et al. (1996) Functional recovery in GDNF-treated parkinsonian monkeys. Nature 380, 252–255.
Gouin, A., Bloch-Gallego, E., Tanaka, H., Rosenthal, A., and Henderson, C. E. (1996) Transforming growth factor-beta 3, glial cell line-derived neurotrophic factor, and fibroblast growth factor-2, act in different manners to promote motoneuron survival in vitro. J. Neurosci. Res. 43, 454–464.
Greenamyre, J. T., Eller, R. V., Zhang, Z., Ovadia, A., Kurlan, R., and Gash, D. M. (1994) Antiparkinsonian effects of Remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson’s disease. Ann. Neurol. 35, 655–661.
Hebert, M. A. and Gerhardt, G. A. (1997) Behavioral and neurochemical effects of intranigral GDNF administration on aged Fischer 344 rats. J. Pharmacol. Exp. Ther.,in press.
Hebert, M. A., van Horne, C. G., Hoffer, B. J., and Gerhardt, G. A. (1996) Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and micro-dialysis. J. Pharmacol. Exp. Ther. 279, 1181–1190.
Hellmich, H. L., Kos, L., Cho, E. S., Mahon, K. A., and Zimmer, A. (1996) Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions. Mech. Devel. 54, 95–105.
Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. N., Lemeulle, C., Armanini, M., et al. (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062–1064.
Ho, A., Gore, A. C., Weickert, C. S., and Blum, M. (1995) Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. Neuroreport 6, 1326–1330.
Hoffer, B. J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.-F. H., and Gerhardt, G. A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107–111.
Hornykiewicz, O. (1993) Parkinson’s disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neurol. 60, 140–147.
Hou, J.-G. G., Lin, L.-F. H., and Mytilineou, C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66, 74–82.
Hudson, J., Granholm, A.-C., Gerhardt, G., Henry, M. A., Hoffman, A., Biddle, P., et al. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425–432.
Humpel, C., Hoffer, B., Stromberg, I., Bektesh, S., Collins, F., and Olson, L. (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59, 791–795.
Jellinger, K. (1986) Overview of morphological changes in Parkinson’s disease. Adv. Neurol. 45, 1–18.
Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., et al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113–1124.
Johansson, M., Friedemann, M., Hoffer, B., and Stromberg, I. (1995) Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic graphs in oculo. Exp. Neurol. 134, 25–34.
Kearns, C. M. and Gash, D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104–111.
Kearns, C. M., Cass, W. A., Smoot, K., Kryscio, R. and Gash, D. M. (1997) GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis. J. Neurosci.,in press.
Krieglstein, K., Suter-Crazzolara, C., Fischer, W. H., and Unsicker, K. (1995) TGF-(3 super-family members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14, 736–742.
Kurlan, R., Kim, M. H., and Gash, D. M. (1991) Oral levodopa dose-response study in MPTPinduced hemiparkinsonism monkeys: assessment with a new rating scale for monkey parkinsonism. Mov. Disord. 6, 111–118.
Li, L., Wu, W., Lin, L.-F. H., Lei, M., Oppenheim, R. W., and Houenou, L. J. (1995) Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92, 9771–9775.
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130–1132.
Lin, L.-F. H., Zhang, T. J., Collins, F., and Armes, L. G. (1994) Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63, 758–768. Lindsay, R. M. (1995) Neuron saving schemes. Nature 373, 289, 290.
Martin, D., Miller, G., Rosendahl, M., and Russell, D. A. (1995) Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat. Brain Res. 683, 172–178.
Massagué, J. (1996) Crossing receptor boundaries. Nature 322, 29, 30.
Miyoshi, Y., Zhang, Z., Ovadia, A., Lapchak, P. A., Collins, F., Hilt, D., Lebel, C., Kryscio, R. and Gash, M. (1997) Glial cell line-derived neurotrophic factor levodopa interactions and reduction of side effects in parkinsonian monkeys. Ann. Neurol.,in press.
Moore, M. W., Klein, R. D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., et al. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76–79.
Mount, H. T. J., Dean, D. O., Alberch, J., Dreyfus, C. F., and Black, I. B. (1995) Glial cell lined-derived neurotrophic factor promotes the survival and morphological differentiation of Purkinje cells. Proc. Natl. Acad. Sci. USA 92, 9092–9096.
Opacka-Juffry, J., Ashworth, S., Hume, S. P., Martin, D., Brooks, D. J., and Blunt, S. B. (1995) GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET. Neuroreport 7, 348–352.
Oppenheim, R. W., Houenou, L. J., Johnson, J. E., Lin, L.-F. H., Li, L., Lo, A. C., et al. (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344–346.
Ovadia, A., Zhang, Z., and Gash, D. M. (1995) Increased susceptibility to MPTP toxicity in middle-aged rhesus monkeys. Neurobiol. Aging 16, 931–937.
Petty, B. G., Cornblath, D. R., Adornato, B. T., Chaudhry, V., Flexner, C., Wachsman, M., Sinicropi, D., Burton, L. E., and Peroutka, S. J. (1994) The effects of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36, 244–246.
Pichel, J. G., Shen, L., Sheng, H. Z., Granholm, A.-C., Drago, J., Grinberg, A., et al. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382, 73–76.
Roberts, A. C., De Salvia, M. A., Wilkinson, L. S., Collins, P., Muir, J. L., Everitt, B. J., and Robbins, T. W. (1994) 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J. Neurosci. 14, 2531–2544.
Sagot, Y., Tan, S. A., Hammang, J. P., Aebischer, P., and Kato, A. C. (1996) GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335–2341.
Sanchez, M. P., Silos-Santiago, I., Frisén, J., He, B., Lira, S. A., and Barbacid M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70–73.
Sauer, H., Rosenblad, C., and Bjorklund, A. (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor ß3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesions. Proc. Natl. Acad. Sci. USA 92, 8935–8939.
Schaar, D. G., Sieber, B.-A., Dreyfus, C. F., and Black, I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 124, 368–371.
Schindelhauer, D., Schuffenhauer, S., Gasser, T., Steinkasserer, A., and Meitinger, T. (1995) The gene coding for glial cell line derived neurotrophic factor (GDNF) maps to chromosome 5p12—p13.1. Genomics 28, 605–607.
Schmidt-Kastner, R., Tomac, A., Hoffer, B., Bektesh, S., Rosenzweig, B., and Olson, L. (1994) Glial cell line-derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Mol. Brain Res. 26, 325–330.
Shults, C. W., Kimber, T., and Martin, D. (1996) Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Neuroreport 7, 627–631.
Springer, J. E., Mu, X., Bergmann, L. W., and Trojanowski, J. Q. (1994) Expression of GDNF mRNA in rat and human nervous tissue. Exp. Neurol. 127, 167–170.
Springer, J. E., Seeburger, J. L., He, J., Gabrea, A., Blankenhorn, E. P., and Bergman, L. W. (1995) cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle. Exp. Neurol. 131, 47–52.
Strömberg, I., Björklund, L., Johansson, M., Tomac, A., Collins, F., Olson, L., Hoffer, B., and Humpel, C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124, 401–412.
Suter-Crazzolara, C., and Unsicker, K. (1994) GDNF is expressed in two forms in many tissues outside the CNS. Neuroreport 5, 2486–2488.
Suvanto, P., Hiltunen, J. O., Arumae, U., Moshnyakov, M., Sariola, H., Sainio, K., and Saarma, M. (1996) Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. Eur. J. Neurosci. 8, 816–822.
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ogren, S. O., Young, D., Hoffer, B. J., and Olson, L. (1995a) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335–339.
Tomac, A., Widenfalk, J., Lin, L.-F. H., Kohno, T., Ebendal, T., Hoffer, B. J., and Olson, L. (1995b) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92, 8274–8278.
Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80–83.
Trupp, M., Ryden, M., Jornvall, H., Funakoshi, H., Timmusk, T., Arenas, E., and Ibanez, C. F. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137–148.
Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.-S., Sieber, B.-A., Grigoriou, M., et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-onocogene. Nature 381, 785–789.
Williams, L. R., Inouye, G., Cummins, V., and Pelleymounter, M. A. (1996) Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-drérived neurotrophic factor. J. Pharmacol. Exp. Ther. 277, 1140–1151.
Yan, Q., Matheson, C., and Lopez, O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341–344.
Zurn, A. D., Baetge, E. E., Hammang, J. P., Tan, S. A., and Aebischer, P. (1994) Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones. Neuroreport 6, 113–118.
Zurn, A. D., Winkel, L., Menoud, A., Djabali, K., and Aebischer, P. (1996) Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro. J. Neurosci. Res. 44, 133–141.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cass, W.A., Kearns, C.M., Gash, D.M. (1998). Protective and Regenerative Properties of GDNF in the Central Nervous System. In: Mattson, M.P. (eds) Neuroprotective Signal Transduction. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-475-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-59259-475-7_8
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5968-6
Online ISBN: 978-1-59259-475-7
eBook Packages: Springer Book Archive